← Evidence map

ArticleBMC cancer2020

miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1.

Yang Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33109107